Implementing the First Outpatient Parenteral Antimicrobial Therapy (OPAT) Program to Utilize Disposable Elastomeric Pumps in the Gulf Region: Results From a Tertiary Teaching Hospital in the Kingdom of Saudi Arabia
- PMID: 34900504
- PMCID: PMC8649972
- DOI: 10.7759/cureus.20179
Implementing the First Outpatient Parenteral Antimicrobial Therapy (OPAT) Program to Utilize Disposable Elastomeric Pumps in the Gulf Region: Results From a Tertiary Teaching Hospital in the Kingdom of Saudi Arabia
Abstract
Objectives To describe the implementation process, safety, and efficacy outcomes, as well as cost-effectiveness, of the first outpatient parenteral antimicrobial therapy (OPAT) program to utilize disposable elastomeric pumps in the Kingdom of Saudi Arabia and the entire Gulf region. Methods This OPAT program was initiated in May 2018 and was administered through a multidisciplinary team that included the home medicine department, pharmacy department, nursing department, and the infectious diseases service. The device used was the Intermate® (Baxter, Deerfield, Illinois) elastomeric pump. After consultation with an infectious diseases physician, eligible patients were discharged home to complete the remainder of their antimicrobial treatment, which was self-administered via the elastomeric devices. Results From May 2018 to December 2019, 47 patients received 55 courses of OPAT via the new program. A total of 2,869 pumps were used during that period to provide 927 days of antimicrobial therapy in the home setting. Most patients completed the program successfully with no reported significant OPAT-related complications such as catheter-related infections. Four patients were re-admitted for relapse of infections and one patient was re-admitted for colistin-induced nephrotoxicity. No mortality was reported for any patient during OPAT treatment and 30 days after program completion. Conclusions The implementation of this novel OPAT program was safe, effective, and offered significant cost-savings to our institution. The entire process was very dynamic and was centered around proper patient selection and education as well as excellent communication between patients and the entire multidisciplinary team involved in the program. We hope that these results will encourage other institutions in the region to implement similar OPAT programs to alleviate the existing bed crisis due to the ongoing COVID-19 pandemic.
Keywords: antibiotics; elastomeric pumps; home health care; infections; outpatients intravenous antimicrobial therapy (opat).
Copyright © 2021, Zikri et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States.J Clin Pharm Ther. 2022 Feb;47(2):211-217. doi: 10.1111/jcpt.13550. Epub 2021 Oct 26. J Clin Pharm Ther. 2022. PMID: 34699089
-
Effectiveness and safety of a disposable elastomeric continuous infusion pump for outpatient parenteral antimicrobial therapy (OPAT) in a UK setting.J Chemother. 2024 Apr;36(2):119-126. doi: 10.1080/1120009X.2023.2277507. Epub 2023 Nov 9. J Chemother. 2024. PMID: 37942621
-
Optimising patient safety when using elastomeric pumps to administer outpatient parenteral antibiotic therapy.Br J Nurs. 2016 Oct 27;25(19):S22-S27. doi: 10.12968/bjon.2016.25.19.S22. Br J Nurs. 2016. PMID: 27792443
-
[Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections].Med Mal Infect. 2006 Mar;36(3):132-7. doi: 10.1016/j.medmal.2006.01.002. Epub 2006 Mar 31. Med Mal Infect. 2006. PMID: 16580802 Review. French.
-
Successful Integration of Clinical Pharmacists in an OPAT Program: A Real-Life Multidisciplinary Circuit.Antibiotics (Basel). 2022 Aug 19;11(8):1124. doi: 10.3390/antibiotics11081124. Antibiotics (Basel). 2022. PMID: 36009993 Free PMC article. Review.
Cited by
-
Dual Viral Infections and Para-Pneumonic Effusion in a Pediatric Patient: A Case of Respiratory Syncytial Virus and COVID-19 Complication.Cureus. 2024 Dec 22;16(12):e76176. doi: 10.7759/cureus.76176. eCollection 2024 Dec. Cureus. 2024. PMID: 39840216 Free PMC article.
-
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177. J Antimicrob Chemother. 2024. PMID: 38842523 Free PMC article. Review.
-
Clinical and patient-reported outcomes of self-administered outpatient parenteral antimicrobial treatment (S-OPAT): a scoping review.Infection. 2025 May 12. doi: 10.1007/s15010-025-02549-1. Online ahead of print. Infection. 2025. PMID: 40354030
-
Evaluation of the outpatient parenteral antimicrobial therapy (OPAT) service in Malaysian public hospitals: a mixed-methods study protocol.BMJ Open. 2025 Jun 24;15(6):e100292. doi: 10.1136/bmjopen-2025-100292. BMJ Open. 2025. PMID: 40555441 Free PMC article.
References
-
- 2018 Infectious Diseases Society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy. Norris AH, Shrestha NK, Allison GM, et al. Clin Infect Dis. 2019;68:0–35. - PubMed
-
- Outpatient intravenous medications in the management of cystic fibrosis. Rucker RW, Harrison GM. https://pubmed.ncbi.nlm.nih.gov/4213282/ Pediatrics. 1974;54:358–360. - PubMed
-
- Factors associated with successful completion of outpatient parenteral antibiotic therapy (OPAT): a 10-year review from a large West London service. Hatcher J, Costelloe C, Cele R, et al. Int J Antimicrob Agents. 2019;54:207–214. - PubMed
-
- Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by hospital at home units in Spain. González-Ramallo VJ, Mirón-Rubio M, Mujal A, Estrada O, Forné C, Aragón B, Rivera AJ. Int J Antimicrob Agents. 2017;50:114–118. - PubMed
-
- Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan. Hase R, Yokoyama Y, Suzuki H, et al. Int J Infect Dis. 2020;95:210–215. - PubMed
LinkOut - more resources
Full Text Sources